Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi, +17

The Lancet

Surgical OncologyMedicineCancer ManagementBronchial NeoplasmThoracic Surgery +8

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, +28

Nature Immunology

Cancer ImmunosurveillanceAutoimmune DiseaseT-regulatory CellPd-1 Expression BalanceClinical Efficacy +10

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai, Shohei Koyama, Kota Itahashi, +43

Cancer Cell

Cancer ImmunosurveillancePd-1 ExpressionMedicineT-regulatory CellImmunology +9

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage, +9

Journal of Thoracic and Cardiovascular Surgery

Interventional PulmonologyPulmonary CareOutcomes ResearchThoracic SurgerySurgery +6

Predominant infiltration of macrophages and CD8⁺ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

Osamu Kawai, Genichiro Ishii, Kaoru Kubota, +9

Cancer

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer

Kenji Suzuki, Shun‐ichi Watanabe, Masashi Wakabayashi, +9

Journal of Thoracic and Cardiovascular Surgery

Single-arm StudySurgical OncologyMedical ImagingMedicineSublobar Resection +9

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

Keiju Aokage, Kenji Suzuki, Hisashi Saji, +23

The Lancet Respiratory Medicine

Surgical OncologyPhase 3MedicineTumour DiameterCancer Management +8

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung

Tomohiro Miyoshi, Shigeki Umemura, Yuki Matsumura, +16

Clinical Cancer Research

Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer

Aritoshi Hattori, Kenji Suzuki, Kazuya Takamochi, +15

Journal of Thoracic and Cardiovascular Surgery

Prognostic ImpactOncologic ImagingGround-glass Opacity ComponentMedicinePathology +5

Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer

Keiju Aokage, Tomohiro Miyoshi, Genichiro Ishii, +6

Journal of Thoracic Oncology

Clinical StageCorresponding Pathological FindingsMedicineGround Glass OpacityBronchial Neoplasm +6